The API Innovation Center participated in a panel discussion, “Reshoring US Pharma: The Realities,” sponsored by US Pharmacopeia, at CPHI North America. Our Chief Operating Officer, Kevin Webb, joined industry experts to delve into strategies and challenges surrounding reshoring critical medicines within the pharmaceutical sector. Prior to this engaging event, Kevin shared exclusive insights in a Q&A session, emphasizing the imperative of domestic manufacturing for essential medications.

Read the Q+A interview from Contract Pharma to learn more.